Effect of COVID-19 on Platelet Mitochondrial Bioenergetic, Antioxidants and Oxidative Stress in Infertile Men.
COVInfertility
Effect of COVID-19 on Spermiogram, Platelet Mitochondrial Bioenergetic, Antioxidants and Oxidative Stress in Infertile Men
1 other identifier
interventional
45
1 country
1
Brief Summary
To verify the hypothesis that infertility and the effect of SARS-CoV-2 on infertility may damage platelet mitochondrial bioenergetics and endogenous coenzyme Q10 levels in infertile men.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedFirst Submitted
Initial submission to the registry
June 15, 2022
CompletedFirst Posted
Study publicly available on registry
June 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedJune 22, 2022
January 1, 2022
9 months
June 15, 2022
June 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (15)
Clinical symptoms
Clinical symptoms: infertile patients without COVID-19 (vaccinated, or none vaccinated) Clinical symptoms patients after COVID-19
15 minutes
Damaged platelet mitochondrial bioenergetics 1
Basal oxygen consumption rate in intact platelets (ce)
1 day
Damaged platelet mitochondrial bioenergetics 2
rate of mitochondria LEAK respiration with CI-linked substrates (1PM - state 4)
1 day
Damaged platelet mitochondrial bioenergetics 3
CI-linked respiration coupled with ATPproduction (2D-CI-linked oxidative phosphorylation capacity), respiration after addition of cytochrome c (2C).
1 day
Damaged platelet mitochondrial bioenergetics 4
Maximal oxidative capacity (the electron transfer capacity -ET), after uncoupler titration (3U).
1 day
Damaged platelet mitochondrial bioenergetics 5
After addition of exogenous substrate glutamate (4G) non-coupled mitochondrial oxygen consumption.
1 day
Damaged platelet mitochondrial bioenergetics 6
Non-coupled oxygen consumption with CI\&CII-linked substrate (5S) improvement of mitochondrial parameters representing OXPHOS- and electron tranport capacity (ET-capacity).
1 day
Endogenous coenzyme Q10-TOTAL 1
CoQ10-TOTAL in: Platelets (pmol.10-9 cells)
1 day
Endogenous coenzyme Q10-TOTAL 2
CoQ10-TOTAL in: Blood (µmol.L-1)
1 day
Endogenous coenzyme Q10-TOTAL 3
CoQ10-TOTAL in: Plasma (µmol.L-1)
1 day
Endogenous coenzyme TBARS
Endogenous concentration of CoQ10-TOTAL (ubiquinone + ubiquinol) in platelets, blood and plasma CoQ10-TOTAL in: TBARS in plasma (µmol.L-1).
1 day
Sperm analysis 1
standard spermiogram examination (volume, pH, number, motility and pathology) in the broker chamber
1 day
Sperm analysis 2
mioxsys for redox potential
1 day
Sperm analysis 3
Vitalsperm (eosin-nigrosine staining) for sperm vitality
1 day
Sperm analysis 4
anti-sperm antibody (IgG) test
1 day
Study Arms (3)
infertile men with post-COVID-19 (vaccinated or without vaccination)
ACTIVE COMPARATOR15 infertile men with post-COVID-19 (vaccinated or without vaccination)
infertile men without post-COVID-19 (vaccinated or without vaccination)
ACTIVE COMPARATOR15 infertile men without post-COVID-19 (vaccinated or without vaccination)
Control: 15 healthy men volunteers (no COVID-19, no other pathologies)
ACTIVE COMPARATOR15 healthy men volunteers (no COVID-19, no other pathologies) as control group
Interventions
Diagnostic Test: 2x14 ml of peripheral blood collected in the tube with anticoagulant, for platelet isolation, respirometry mitochondrial analysis, antioxidants (coenzyme Q10, vitamin E, gamma-tocopherol, beta-carotene) and TBARS estimation. Sperm analysis: standard spermiogram examination (volume, pH, number, motility and pathology) in the broker chamber, as well as extended examinations: mioxsys for redox potential, Vitalsperm (eosin-nigrosine staining) for sperm vitality and anti-sperm antibody (IgG) test.
Eligibility Criteria
You may qualify if:
- Infertile patients without COVID-19
- Infertile patients after COVID-19 Control group: healthy volunteers
You may not qualify if:
- disagreement with informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Comenius Universitylead
- GYN-FIVcollaborator
Study Sites (1)
Pharmacobiochemical Laboratory of Third Department of Internal Medicine, Faculty of Medicine Comenius University in Bratislava
Bratislava, 81108, Slovakia
Related Publications (12)
Sheweita SA, Tilmisany AM, Al-Sawaf H. Mechanisms of male infertility: role of antioxidants. Curr Drug Metab. 2005 Oct;6(5):495-501. doi: 10.2174/138920005774330594.
PMID: 16248841RESULTGvozdjakova A, Kucharska J, Dubravicky J, Mojto V, Singh RB. Coenzyme Q(1)(0), alpha-tocopherol, and oxidative stress could be important metabolic biomarkers of male infertility. Dis Markers. 2015;2015:827941. doi: 10.1155/2015/827941. Epub 2015 Feb 25.
PMID: 25810566RESULTGvozdjakova A, Sumbalova Z, Kucharska J, Chladekova A, Rausova Z, Vancova O, Komlosi M, Ulicna O, Mojto V. Platelet mitochondrial bioenergetic analysis in patients with nephropathies and non-communicable diseases: a new method. Bratisl Lek Listy. 2019;120(9):630-635. doi: 10.4149/BLL_2019_104.
PMID: 31475544RESULTGvozdjakova A, Sumbalova Z, Kucharska J, Komlosi M, Rausova Z, Vancova O, Szamosova M, Mojto V. Platelet Mitochondrial Respiration, Endogenous Coenzyme Q10 and Oxidative Stress in Patients with Chronic Kidney Disease. Diagnostics (Basel). 2020 Mar 23;10(3):176. doi: 10.3390/diagnostics10030176.
PMID: 32210203RESULTGvozdjakova A, Sumbalova Z, Kucharska J, Szamosova M, Capova L, Rausova Z, Vancova O, Mojto V, Langsjoen P, Palacka P. Platelet mitochondrial respiration and coenzyme Q10 could be used as new diagnostic strategy for mitochondrial dysfunction in rheumatoid diseases. PLoS One. 2021 Sep 28;16(9):e0256135. doi: 10.1371/journal.pone.0256135. eCollection 2021.
PMID: 34582480RESULTSumbalova Z, Kucharska J, Palacka P, Rausova Z, Langsjoen PH, Langsjoen AM, Gvozdjakova A. Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19. Bratisl Lek Listy. 2022;123(1):9-15. doi: 10.4149/BLL_2022_002.
PMID: 34967652RESULTPesta D, Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol. 2012;810:25-58. doi: 10.1007/978-1-61779-382-0_3.
PMID: 22057559RESULTAbobaker A, Raba AA. Does COVID-19 affect male fertility? World J Urol. 2021 Mar;39(3):975-976. doi: 10.1007/s00345-020-03208-w. Epub 2020 Apr 21. No abstract available.
PMID: 32318855RESULTRajak P, Roy S, Dutta M, Podder S, Sarkar S, Ganguly A, Mandi M, Khatun S. Understanding the cross-talk between mediators of infertility and COVID-19. Reprod Biol. 2021 Dec;21(4):100559. doi: 10.1016/j.repbio.2021.100559. Epub 2021 Sep 1.
PMID: 34547545RESULTGvozdjakova A, Klauco F, Kucharska J, Sumbalova Z. Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19? Bratisl Lek Listy. 2020;121(11):775-778. doi: 10.4149/BLL_2020_126.
PMID: 33164536RESULTBoguenet M, Bouet PE, Spiers A, Reynier P, May-Panloup P. Mitochondria: their role in spermatozoa and in male infertility. Hum Reprod Update. 2021 Jun 22;27(4):697-719. doi: 10.1093/humupd/dmab001.
PMID: 33555313RESULTKhalili MA, Leisegang K, Majzoub A, Finelli R, Panner Selvam MK, Henkel R, Mojgan M, Agarwal A. Male Fertility and the COVID-19 Pandemic: Systematic Review of the Literature. World J Mens Health. 2020 Oct;38(4):506-520. doi: 10.5534/wjmh.200134. Epub 2020 Aug 14.
PMID: 32814369RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Gvozdjáková, Prof.Dr.DSc.
CU in Bratislava, Faculty of Medicine, Pharmacobiochemical Laboratory of 3rd department of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2022
First Posted
June 16, 2022
Study Start
April 1, 2022
Primary Completion
December 31, 2022
Study Completion
March 30, 2023
Last Updated
June 22, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share